Ikena Oncology News

Ikena Oncology Analyst Ratings

BenzingaMay 14 08:27 ET

Ikena Oncology (IKNA) Gets a Buy From Wedbush

TipRanksMay 14 07:55 ET

Ikena Oncology Analyst Ratings

BenzingaMar 19 07:03 ET

Ikena Oncology's Promising Drug Pipeline Merits a Buy Rating

TipRanksMar 12 18:05 ET

Ikena Oncology Analyst Ratings

BenzingaMar 12 10:48 ET

Ikena Oncology (IKNA) Gets a Buy From Wedbush

TipRanksJan 22 14:24 ET

Buy Rating on Ikena Oncology: Undervalued Assets and Promising Pipeline in Oncology Sector

TipRanksJan 22 13:46 ET

Ikena Oncology Analyst Ratings

BenzingaJan 19 07:15 ET

HC Wainwright Adjusts Ikena Oncology Price Target to $11 From $18, Maintains Buy Rating

MT NewswiresNov 10, 2023 08:13 ET

Wedbush Lowers Ikena Oncology's Price Target to $8 From $11, Moves Estimates Launch Timings for IK-930; Maintains Outperform Rating

MT NewswiresNov 10, 2023 07:03 ET

HC Wainwright & Co. Maintains Buy on Ikena Oncology, Lowers Price Target to $11

BenzingaNov 9, 2023 17:53 ET

Ikena Oncology Analyst Ratings

BenzingaNov 9, 2023 17:51 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Adicet Bio (ACET), Biogen (BIIB) and Ikena Oncology (IKNA)

TipRanksNov 9, 2023 14:09 ET

Positive Outlook for Ikena Oncology: Buy Rating Reiterated Amid Promising IK-930 Drug Developments

TipRanksNov 9, 2023 13:30 ET

Wedbush Initiates Coverage On Ikena Oncology With Outperform Rating, Announces Price Target of $11

BenzingaSep 22, 2023 04:25 ET

Ikena Oncology Analyst Ratings

BenzingaSep 22, 2023 04:23 ET

HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $18 Price Target

BenzingaAug 10, 2023 13:51 ET

Ikena Oncology Analyst Ratings

BenzingaAug 10, 2023 13:50 ET

Ikena Oncology Analyst Ratings

BenzingaAug 7, 2023 12:27 ET

H.C. Wainwright Keeps Their Buy Rating on Ikena Oncology (IKNA)

TipRanksAug 7, 2023 10:25 ET